Why is P & G Health Ltd falling/rising?

As of 01-Aug, Procter & Gamble Health Ltd's stock is rising, with a current price of Rs 6,199.70, reflecting an increase of 324.1 or 5.52%. The stock reached a new 52-week high of Rs 6,490 today, outperforming its sector by 8.68%. Over the past week, the stock has gained 6.31%, and year-to-date, it has risen by 18.54%, significantly outperforming the benchmark Sensex, which has only increased by 3.15% during the same period. The company has demonstrated strong financial performance, with positive results over the last four consecutive quarters, including a remarkable growth in profit before tax and net sales. Additionally, the company enjoys high management efficiency and low debt levels, contributing to investor confidence.
In the broader market context, while the Sensex has experienced a decline of 1.06% over the past week, Procter & Gamble Health Ltd has managed to rise, indicating strong relative performance. The pharmaceuticals and drugs sector has faced a downturn of 3.26%, yet P & G Health Ltd has bucked this trend. However, there are concerns regarding long-term growth, as net sales have only grown at an annual rate of 5.69% over the last five years, and the stock is considered expensive based on its valuation metrics. Despite these risks, the high institutional holdings suggest that informed investors continue to support the stock, which has led to its recent upward movement.